16 June 2020
("Tekcapital", the "Company" or "the Group")
Portfolio Company Update: Guident Ltd.
Tekcapital Plc (AIM: TEK), the UK intellectual property investment group focused on creating marketplace value from investing in university technology, is pleased to announce that Guident Ltd. has appointed several Science Advisory Board Members and has been awarded an additional U.S. patent.
Guident is pleased to announce the appointment of Professor Naphtali Rishe, Professor Hayder Radha and Dr. Marielle S. Gross to its Science Advisory Board.
Professor Rishe is the Founder and Director of the High Performance Database Research Center at Florida International University (FIU) and head of the NSF International FIU-FAU-Dubna-Greenwich Industry-University Cooperative Research Center for Advanced Knowledge Enablement. Rishe is an Eminent Chair Professor in Computer Science and has authored many books on database management, location-based data, health informatics, and high performance computing. He was awarded over US$55 million in research grants by Government and Industry, including NSF, NASA, IBM, DoI, DHS, USGS.
Hayder Radha is a Professor of Electrical and Computer Engineering (ECE) at Michigan State University, the Associate Chair for Research of the ECE Department, and the Director of the Wireless and Video Communications Laboratory. Professor Radha was with Philips Research, where he worked as a Principal Member of Research Staff and then as a Consulting Scientist in the Video Communications Research Department. He previously served as a Member of Technical Staff at Bell Laboratories where he worked in the areas of digital communications, image processing, and broadband multimedia.
Marielle S. Gross, MD, MBE is a Hecht-Levi Fellow at the Johns Hopkins Berman Institute of Bioethics where she will become an affiliate faculty member as she assumes an assistant professorship at the University of Pittsburgh Departments of Obstetrics, Gynecology & Reproductive Sciences and Bioethics & Health Law next month. She has published numerous chapters and scientific papers on ethical imperatives related to implementation of emerging technologies such as blockchain and federated learning, particularly in the healthcare and public health spaces. She has been a member of the Johns Hopkins Distinguished Teaching Society since 2017.
Additionally, Guident has announced the forthcoming issuance of patent # 10,699,580 from the United States Patent and Trademark Office entitled "Methods and Systems for Emergency Handoff of an Autonomous Vehicle." This patent teaches new methods to improve the safety of autonomous vehicles and land-based delivery drones.
According to Allied Market Research, "the autonomous vehicle market is expected to reach $556 billion by 2026 with a CAGR of 39%.1 Contactless or "touch-free" delivery is in high demand due to the COVID 19 pandemic.2,3 Guident believes this increased demand will accelerate the roll-out of land-based delivery drones for food and medicines to improve their availability and reduce the costs of these deliveries.
"We are very pleased to add Dr's Rishe, Radha & Gross to our Science Advisory Board. Their combined experience and knowledge in artificial intelligence software for autonomous vehicles and bioethics will provide valuable insight as we expand the development of our remote monitoring and control center for AV's and land-based delivery drones," said Harald Braun, Guident's Chairman and CEO
Tekcapital owns 100% of the share capital of Guident Ltd.
About Guident, Ltd.
Guident commercializes new IP & technology to enhance the utility, safety, and enjoyment of autonomous vehicles and delivery drones. Using its proprietary IP, Guident is developing artificial intelligent Apps that allow users of AV's to dispatch, monitor and control their vehicles remotely when necessary. To learn more please visitwww.guident.co.
About Tekcapital plc
Tekcapital creates value from investing in new, university-developed intellectual properties and provides a range of IP investment services to make it easy for organisations to commercialise university-developed technology. Tekcapital is quoted on the AIM market of the London Stock Exchange (AIM: symbol TEK) and is headquartered in Oxford, in the UK. For more information, please visit www.tekcapital.com
For further information, please contact:
Clifford M. Gross, Ph.D.
SP Angel Corporate Finance LLP (Nominated Adviser and Joint Broker)
+44 (0) 20 3470 0470
Richard Morrison/Charlie Bouverat (Corporate Finance) Abigail Wayne (Corporate Broking)
Flagstaff Strategic and Investor Communications Tim Thompson/Andrea Seymour/Fergus Mellon
+44 (0) 20 7129 1474
This press release is for informational purposes only. The information herein does not constitute investment advice nor an offer to invest and may contain statements related to our future business and financial performance and future events or developments involving Guident or Tekcapital that may constitute forward-looking statements. These statements may be identified by words such as "expect," "look forward to," "anticipate" "intend," "plan," "believe," "seek," "estimate," "will," "project" or words of similar meaning. We may also make forward-looking statements in other reports, in presentations, in material delivered to customers, stakeholders and in press releases. In addition, our representatives may from time to time make oral forward-looking statements. Such statements may be based on the current expectations and certain assumptions of Guident' and/or Tekcapital's management. Please note that these are subject to a number of risks, uncertainties and factors, including, but not limited to those described in various disclosures. Should one or more of these risks or uncertainties materialise, or should underlying expectations not occur or assumptions prove incorrect, actual results, performance or achievements of Guident or Tekcapital may vary materially from those described explicitly or implicitly in the relevant forward-looking statement. Neither Guident nor Tekcapital intends, nor assumes any obligation, to update or revise these forward-looking statements in light of developments which differ from those anticipated.